A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males

Clinical trial NCT06465914 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06465914
Sponsor: Shanghai Bovax Biotechnology Co., Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Genital Wart Penile Cancer Anal Cancer PIN-1 PIN2 PIN3 AIN1 AIN2 AIN3 HPV-Related Carcinoma

Start date: 2024-07-11
Primary completion: 2027-07-30
Enrollment: 9000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.